Ekso Bionics Holdings Stock Today
| EKSO Stock | USD 1.21 0.07 5.47% |
Performance0 of 100
| Odds Of DistressOver 84
|
Ekso Bionics is selling at 1.21 as of the 19th of April 2024; that is -5.47% down since the beginning of the trading day. The stock's open price was 1.28. Ekso Bionics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Ekso Bionics Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 16th of January 2014 | Category Healthcare | Classification Health Care |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company was incorporated in 2005 and is headquartered in Richmond, California. The company has 17.9 M outstanding shares of which 134.27 K shares are currently shorted by private and institutional investors with about 0.55 trading days to cover. More on Ekso Bionics Holdings
Moving together with Ekso Stock
| 0.85 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.62 | AHG | Akso Health Group | PairCorr |
Moving against Ekso Stock
| 0.79 | ELMD | Electromed | PairCorr |
| 0.74 | GCTK | GlucoTrack | PairCorr |
| 0.71 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
| 0.68 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.67 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
| 0.61 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
| 0.5 | RMD | ResMed Inc Earnings Call This Week | PairCorr |
Ekso Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ekso Bionics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ekso Bionics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Co-Founder, CEO and Director | Nathan Harding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Machinery (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Machinery, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Ekso Bionics report their recommendations after researching Ekso Bionics' financial statements, talking to executives and customers, or listening in on Ekso Bionics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ekso Bionics Holdings. The Ekso consensus assessment is calculated by taking the average forecast from all of the analysts covering Ekso Bionics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Ekso Bionics' liquidity, profitability, solvency, and operating efficiency, Ekso Bionics Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Ekso Bionics Holdings is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ekso Bionics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ekso Bionics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ekso Bionics' financial leverage. It provides some insight into what part of Ekso Bionics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ekso Bionics Holdings (EKSO) is traded on NASDAQ Exchange in USA. It is located in 101 Glacier Point, San Rafael, CA, United States, 94901 and employs 70 people. Ekso Bionics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 21.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ekso Bionics's market, we take the total number of its shares issued and multiply it by Ekso Bionics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ekso Bionics Holdings conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 17.9 M outstanding shares of which 134.27 K shares are currently shorted by private and institutional investors with about 0.55 trading days to cover.
Ekso Bionics Holdings currently holds about 31.91 M in cash with (12.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Ekso Bionics Probability Of Bankruptcy
Ownership AllocationEkso Bionics holds a total of 17.9 Million outstanding shares. Ekso Bionics Holdings shows 13.0 percent of its outstanding shares held by insiders and 7.61199999999999 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ekso Ownership Details
Ekso Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Ekso Bionics jumping above the current price in 90 days from now is about 92.78%. The Ekso Bionics Holdings probability density function shows the probability of Ekso Bionics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Ekso Bionics Holdings has a beta of -0.7008 suggesting as returns on the benchmark increase, returns on holding Ekso Bionics are expected to decrease at a much lower rate. During a bear market, however, Ekso Bionics Holdings is likely to outperform the market. Additionally, ekso Bionics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Ekso Bionics to move above the current price in 90 days from now is about 92.78 (This Ekso Bionics Holdings probability density function shows the probability of Ekso Stock to fall within a particular range of prices over 90 days) .
Ekso Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Ekso Bionics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ekso Bionics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ekso Bionics' value.| Instituion | Recorded On | Shares | |
| Legato Capital Management Llc | 2023-12-31 | 12 K | |
| Atria Wealth Solutions, Inc. | 2023-12-31 | 12 K | |
| Xtx Topco Ltd | 2023-12-31 | 11.2 K | |
| Advisor Group Holdings, Inc. | 2023-12-31 | 7.3 K | |
| Simplex Trading, Llc | 2023-12-31 | 3 K | |
| Ubs Group Ag | 2023-12-31 | 906 | |
| Group One Trading, Lp | 2023-12-31 | 460 | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 362 | |
| Harbour Investments, Inc. | 2023-12-31 | 358 | |
| Vanguard Group Inc | 2023-12-31 | 436.9 K | |
| Essex Investment Management Company, Llc | 2023-12-31 | 157.7 K |
Ekso Bionics Historical Income Statement
Ekso Bionics Holdings Income Statement is one of the three primary financial statements used for reporting Ekso's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Ekso Bionics Holdings revenue and expense. Ekso Bionics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Ekso Bionics' Depreciation And Amortization is very stable compared to the past year. As of the 19th of April 2024, Interest Income is likely to grow to about 7.2 M, while Interest Expense is likely to drop about 271.3 K. View More FundamentalsEkso Stock Against Markets
Picking the right benchmark for Ekso Bionics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ekso Bionics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ekso Bionics is critical whether you are bullish or bearish towards Ekso Bionics Holdings at a given time. Please also check how Ekso Bionics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ekso Bionics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Ekso Bionics Corporate Directors
Ekso Bionics corporate directors refer to members of an Ekso Bionics board of directors. The board of directors generally takes responsibility for the Ekso Bionics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ekso Bionics' board members must vote for the resolution. The Ekso Bionics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Howard Palefksy | Director | Profile | |
| Dan Boren | Independent Director | Profile | |
| Stanley Stern | Independent Director | Profile | |
| Theodore Wang | Director | Profile |
How to buy Ekso Stock?
Before investing in Ekso Bionics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ekso Bionics. To buy Ekso Bionics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ekso Bionics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ekso Bionics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ekso Bionics Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ekso Bionics Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ekso Bionics Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Ekso Stock please use our How to Invest in Ekso Bionics guide.
Already Invested in Ekso Bionics Holdings?
The danger of trading Ekso Bionics Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ekso Bionics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ekso Bionics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ekso Bionics Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Ekso Stock analysis
When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share 1.318 | Quarterly Revenue Growth 0.365 | Return On Assets (0.27) | Return On Equity (0.80) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.